Table 1.
Patient characteristics
| All patients (n = 31) | IR‐Tac–LCPT–ER‐Tac (n = 16) | IR‐Tac–ER‐Tac–LCPT (n = 15) | |
|---|---|---|---|
| Age (years), mean (SD) | 48.3 (12.1) | 50.1 (11.0) | 46.3 (13.3) |
| Male sex, n (%) | 18 (58.1) | 9 (56.3) | 9 (60.0) |
| Race, n (%) | |||
| Caucasian | 23 (74.2) | 13 (81.3) | 10 (66.7) |
| African American | 7 (22.6) | 2 (12.5) | 5 (33.3) |
| Other | 1 (3.2) | 1 (6.3) | 0 (0) |
| Donor type, n (%) | |||
| Deceased | 3 (9.7) | 1 (6.3) | 2 (13.3) |
| Living | 28 (90.3%) | 15 (93.8%) | 13 (86.7%) |
| Years since transplant to study, mean (min–max) | 6.1 (0.7–14.2) | 7.0 (3.2–14.2) | 5.2 (0.7–9.2) |
| Baseline BMI (kg/m2), mean (SD) | 30.4 (4.9) | 30.9 (4.8) | 29.9 (5.1) |
BMI, body mass index; ER‐Tac, extended‐release tacrolimus; IR‐Tac, immediate‐release tacrolimus; LCPT, once‐daily, MeltDose tacrolimus; SD, standard deviation.